Involved in secondary (metastatic) breast cancer in the bone (e.g., by promoting angiogenesis, regulating VEGF bioavailability, contributing to bone remodeling) or prostate cancer (e.g., by influencing bone osteoblastic and osteoclastic activity). The gene discussed is VEGFA; the disease is Familial prostate cancer.